Aldeyra Therapeutics, Inc.
Industry
- Pharmaceuticals
- Biotechnology
Other Names/Subsidiaries
- Aldexa Therapeutics
- Helio Vision
- Neuron Systems
Latest on Aldeyra Therapeutics, Inc.
Roughly a month after receiving its second US Food and Drug Administration complete response letter, Aldeyra said on 5 May that it believes new Phase II data will meet the agency’s requirements and in
The US Food and Drug Administration’s prescription drug user fee goal date calendar for May may be overshadowed by the 31 May goal date for Moderna ’s next-generation COVID-19 vaccine, given a resurg
Despite a second complete response letter from the US Food and Drug Administration to its new drug application for reproxalap in dry eye disease, Aldeyra expects to refile for approval during the midd
Despite the ongoing upheaval across the agency, the US Food and Drug Administration maintained its typical reliability when it came to meeting user fee goal dates in the first quarter of 2025, the Pi